SOAT1 and myeloproliferative neoplasm: To understand the pathogenesis of the BCR-ABL negative myeloproliferative neoplasms (MPNs) solely on the basis of constitutive JAK/STAT signalling resulting from activating mutations in JAK2 [1], MPL [2] or CALR [3] is an oversimplification.